帕金森病相关的α-synuclein突变改变了它的脂质结合状态
Sofiya Maltseva1, Daniel Kerr2, Miah Turke1
1Department of Chemistry, The University of Chicago, Chicago, Illinois; James Franck Institute, The University of Chicago, Chicago, Illinois.
Biophysical journal
|May 4, 2024
概括
帕金森病对α-synuclein (α-synuclein) 的突变改变了其两个螺旋形区域与脂质膜的结合方式. 结合平衡的这种破坏可能会导致帕金森病的进展.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 阿尔法-同核素 (α-synuclein) 聚合和脂质结合是帕金森病 (PD) 病原体的核心.
- 在α-synuclein中与疾病相关的突变位于其两个脂结合状状区域内.
- 这些突变对这些螺旋体的差异结合的确切影响仍然不完全理解.
研究的目的:
- 为了研究与帕金森病相关的单点突变如何影响α-synuclein的两个α-螺旋体的脂质膜结合.
- 描述PD相关突变体中单个螺旋体的结合行为.
- 阐明了改变状脂结合平衡在PD进展中的作用.
主要方法:
- 采用托芬光试验量化α-synuclein螺旋体与脂质膜的结合亲和力.
- 检查了脂质耗尽模式中的结合,以探测平衡状态.
- 对多个与PD相关的α-synuclein突变体 (V15A,A30P,E46K,H50Q,G51D,A53T,A53V) 的评估结合特性.
主要成果:
- 与PD相关的突变通常会将平衡结合状态从N端螺旋 (螺旋1) 转移到C端螺旋 (螺旋2) 方向,在较低的脂质度下.
- 在各种突变物中,每个螺旋体具有独特的结合行为.
- 证明突变对螺旋体-脂质相互作用产生差异影响.
结论:
- 破坏α-synuclein和脂质膜的两个α-螺旋体之间的平衡结合是帕金森病进展的潜在机制.
- 这些发现为将α-synuclein突变与PD联系起来的分子机制提供了新的见解.
- 改变α-synuclein突变体的脂质结合动力学代表了帕金森病的可行的治疗标.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
5.9K
相关概念视频
Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
